Solazyme Given Buy Rating at Goldman Sachs Group Inc. (SZYM)
Solazyme (NASDAQ:SZYM)‘s stock had its “buy” rating reaffirmed by research analysts at Goldman Sachs Group Inc. in a report released on Wednesday, Stock Ratings Network reports. They currently have a $14.00 price target on the stock. Goldman Sachs Group Inc.’s price objective would suggest a potential upside of 30.60% from the company’s current price.
Separately, analysts at Robert W. Baird raised their price target on shares of Solazyme (NASDAQ:SZYM) from $12.00 to $16.00 in a research note to investors on Thursday, August 8th. They now have an “outperform” rating on the stock.
One investment analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. Solazyme currently has an average rating of “Buy” and an average target price of $13.50.
Solazyme (NASDAQ:SZYM) traded up 7.46% on Wednesday, hitting $11.52. The stock had a trading volume of 1,008,193 shares. Solazyme has a 52-week low of $6.45 and a 52-week high of $13.09. The stock has a 50-day moving average of $11. and a 200-day moving average of $10.45. The company’s market cap is $717.8 million.
Solazyme (NASDAQ:SZYM) last released its earnings data on Wednesday, August 7th. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.40) by $0.12. The company had revenue of $11.20 million for the quarter, compared to the consensus estimate of $10.66 million. During the same quarter last year, the company posted ($0.27) earnings per share. Solazyme’s revenue was down 17.0% compared to the same quarter last year. On average, analysts predict that Solazyme will post $-1.59 earnings per share for the current fiscal year.
In other Solazyme news, CEO Jonathan Wolfson sold 35,000 shares of Solazyme stock on the open market in a transaction that occurred on Tuesday, September 24th. The stock was sold at an average price of $10.54, for a total value of $368,900.00. Following the completion of the transaction, the chief executive officer now directly owns 230,000 shares in the company, valued at approximately $2,424,200. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.